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ORIGINAL ARTICLE

Prognostic Nutritional Index as a Predictor of
Prognosis in Patients with Chronic Limb Threatening
Ischemia who Underwent Endovascular
Revascularization Therapy
Wai-Kin Chi*, Guang-Ming Tan, Bryan P.Y. Yan
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong,
Hong Kong Special Administrative Region, People's Republic of China

Abstract
Background: Patients with chronic limb-threatening ischemia (CLTI) have poor prognosis. Prognostic nutritional index
(PNI) is an established independent predictor of adverse outcome in various chronic illnesses. The use of PNI in patients
with CLTI has not been studied. To evaluate the impact of PNI on 12-month adverse cardiovascular and limb outcomes
in CLTI patients after endovascular revascularization therapy (ERT).
Methods: 270 consecutive patients with CLTI (mean age 73.7 ± 11.9 years; 53% male) who underwent ERT at a single
tertiary referral hospital between January 2009 and October 2016 were prospectively enrolled and analyzed. Patients
were grouped by tertiles of PNI (lowest ≤37.5; middle 37.6e45.5; and highest >45.5) at baseline deﬁned as 10 £ serum
albumin (g/dL) þ 0.005 £ total lymphocyte count (per mm3). Composite endpoint including all-cause mortality and
amputation was considered as primary endpoint. All-cause mortality and amputation were also analyzed individually as
secondary endpoints at 12-months. Multivariate Cox proportional hazards regression analyses were performed.
Results: Mean PNI of the 3 groups were 32.8, 42.2 and 50.4 respectively. Co-morbidities such as end-stage renal failure,
heart failure and Rutherford classiﬁcations 6 were signiﬁcantly more prevalent in the lowest PNI tertile (all P < 0.05).
Patients in the highest PNI tertile was associated with lowest incidence of 12-month composite endpoint (9.9%), all-cause
mortality (7.7%) and amputation (3.3%) compared to those in the middle (27.0%, 22.5%, 9.0%) and lowest (52.2%, 47.8%,
16.7%) respectively, and reached statistical signiﬁcance (p < 0.05). Multivariate analysis demonstrated high PNI was an
independent protective predictor of composite endpoint (adjusted Hazards Ratio (HR) 0.26, 95% conﬁdence interval (CI):
0.12e0.57) and all-cause mortality (adjusted HR 0.20; 95% CI: 0.09e0.49). Kaplan-Meier analysis revealed that higher PNI
was signiﬁcantly associated with better prognosis with regard to amputation, all-cause mortality and primary composite
endpoint (log rank<0.05).
Conclusions: Our results demonstrated that higher nutritional status deﬁned by prognostic nutritional index (PNI)
predicted lower all-cause mortality and amputation rates in chronic limb-threatening ischemia patients after endovascular revascularization therapy.
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Introduction

T

he incidence and prevalence of peripheral
arterial disease (PAD) increase substantially
with age in both males and females. The presentation of PAD varies from asymptomatic, intermittent
claudication which in turn may lead to loss of independence, to even chronic limb-threatening
ischemia (CLTI). CLTI is at the most severe end of
the lower extremity peripheral artery disease (LEPAD) spectrum and is also one of the leading causes
of non-traumatic lower limb amputation. It is also
strongly associated with excessively high risk for
cardiovascular events, including myocardial infarction, and death [1,2].
With the advance of technology and increased use
of endovascular revascularization therapy (ERT) for
patients with limb ischemia, an endovascular-ﬁrst
approach has been adopted for patients with CLTI
in many specialized centers [3,4]. However, prognosis of patients with CLTI remained poor despite
optimal revascularization, with amputation or morality rate up to 20e30% at 1 year [5e7]. For
example, in the Endovascular treatment for
infrainguinal vessels in patients with chronic limbthreatening ischemia (OLIVE registry, a prospective,
multicenter study in Japan with 12-month followup), the 12-month amputation-free survival (AFS)
rate was 74% [6].
Several predictive scoring models for CLTI patients such as the Bypass versus angioplasty in severe ischemia of the leg (BASIL), Finland National
Vascular (FINNVASC) and 2-year life expectancy
(2YLE) have been developed from clinical trials in
order to predict clinical outcomes before endovascular intervention or surgery. BASIL is a survival
predictor which showed that various factors
including age, history of MI or stroke, tissue loss,
smoking, body mass index (BMI), diabetes, ankle
pressure and number of detectable ankle pressures
were predictive of survival in the model [7]. On the
other hand, FINNVASC risk score suggested that
diabetes, coronary artery disease, presence of foot
gangrene, and urgent operation were independent
predictors of 30-day postoperative mortality and/or
major lower-limb amputation [8]. Whereas, 2-year
life expectancy (2YLE) score demonstrated that age,
BMI, non-ambulatory status, hemodialysis, history
of cerebrovascular disease, left ventricular ejection
factions (LVEF), and tissue loss were the independent prognostic factors for survival [9].
Nutritional status and deﬁcit are important but
often neglected in the above risk scores and
assessment of patients with CLTI. Furthermore,
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patients with CLTI are often complicated with
wound infection, osteomyelitis or even sepsis, and
these would lead to chronic inﬂammation and
negative nutritional balance. Thus, inﬂammationand nutrition-related factors should be investigated
as potential independent prognostic factors in patients with CLTI. Prognostic nutritional index (PNI),
which is calculated from the serum albumin concentration and total lymphocyte counts, is a simple
and objective indicator of postoperative outcomes in
patients undergoing cancer surgery [10]. In the ﬁeld
of cardiovascular disease, Cheng at el also showed
that PNI was independently associated with longterm survival in patients hospitalized for acute heart
failure with either reduced or preserved left ventricular ejection fraction [11]. However, the association between PNI and the overall prognosis of
patients with CLTI following endovascular revascularization therapy has not been explored, and is
therefore the subject of this study.

Materials and methods
Study design
This prospective registry consisted of 270 consecutive patients with CLTI who underwent endovascular revascularization therapy (ERT) at a single
tertiary referral hospital in the Hong Kong Special
Administrative Region of the People's Republic of
China from January 2009 to October 2016.
Subject enrollment
The inclusion criteria were patients having CLTI
with Rutherford classiﬁcation stage 4e6, which were
rest pain (Stage 4), ischemic ulceration not
exceeding ulcers of the digits of the foot (Stage 5)
and severe ischemic ulcers or frank gangrene (Stage
6) respectively [12]. All of these were caused by
chronic infrainguinal occlusive disease. The exclusion criteria were aged below 18 years old, pregnant
or with cognitive disorders or mental disabilities. Clinical Data Analysis & Reporting System
(CDARS), clinical management system (CMS) of
Hospital Authority (HA) and medical chart review
were utilized as for the sources of retrieving
participating patients’ medical history, clinical examinations and operative records. The diagnosis of
diabetes mellitus (DM) was conﬁrmed by the current use of oral hypoglycemic agents or insulin,
together with review of the previous fasting glucose
and Hemoglobin A1c level. End-stage renal failure
(ESRF) was deﬁned as glomerular ﬁltration rate
(GFR) less than 15 ml/min/1.73m2 or dialysis
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dependence. Dialysis modalities were either peritoneal dialysis or hemodialysis. Patients were considered to have a history of coronary artery disease (CAD)
even if they had previously been revascularized with
percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG). Hypertension and
congestive heart failure were determined from the
medical records and conﬁrmed by the use of appropriate medications. Prognostic Nutritional Index (PNI)
was calculated as 10  serum albumin (g/
dL) þ 0.005  total lymphocyte count (per mm3) [13].
To evaluate the prognostic impact of PNI on the clinical outcome in patients with CLTI who underwent
ERT, the enrolled patients were grouped by tertiles of
PNI at baseline. Informed consents were given by all
participating patients before enrollment and the study
protocol was approved by the ethics committee of our
institution.
Decision of endovascular revascularization therapy
(ERT)
The decision to intervene and the method of
treatment were based on the clinical examination,
anatomic evaluation, and judgment of the attending
physician involved. Balloon angioplasty was performed with an appropriately sized balloon that was
chosen to match the non-diseased artery adjacent to
the lesion. Selective stenting was performed at the
discretion of the operator, mainly with bare metal
stents and angiography was performed to assess the
technical result. At the end, only one of the 270 cases
was regarded as technically unsuccessful after
endovascular intervention. After the procedure,
unless contraindicated, all patients were given a
course of double anti-platelet regime (clopidogrel
75mg daily and aspirin 80mg daily) for 4e12 weeks,
and then lifelong aspirin 80mg daily. All of the
enrolled patients were regularly reviewed in outpatient clinics or through clinical management system of Hospital Authority for 12 months.
Study endpoints and deﬁnitions
During the 12-month study period, clinical outcomes were assessed with regard to amputation and
all-cause mortality. Primary composite endpoint
involving amputation and all-cause mortality was
considered as primary endpoint. Amputation, which
refers to above-ankle amputation, and all-cause mortality were considered to be secondary endpoints.
Amputation free survival (AFS) was also evaluated and it was deﬁned as the absence of all-cause
mortality or amputation over a 12-month observation period. Survival was deﬁned as the absence of

all-cause mortality while limb salvage (LS) was
referred as the absence of above-ankle amputation
over the study period.
Statistical analysis
Continuous and categorical data were expressed
as mean ± standard deviation (SD) and numbers
with percentages respectively. Between-group
comparisons on the distribution of baseline characteristics of participants were achieved using chisquare or Fisher's exact test for categorical variables
as appropriate and Kruskal-Wallis test for continuous variables. For those continuous variables with
skewed distribution, they were ﬁrst taken into natural log transformations before linear regression
analysis and Cox proportional hazards analysis.
Multivariate linear regression analysis in stepwise
forward selection on PNI values was conducted to
illustrate the signiﬁcant correlations with other
continuous parameters. In addition, age and gender
of the enrolled patients were included as the potential confounding variables on PNI. Kaplan-Meier
estimates with 95% conﬁdence interval (CI) for the
incidence of study endpoints were conducted to
compare the prognoses of the tertiles of PNI. The
signiﬁcance of its inﬂuence on those endpoints was
further examined with the log-rank test and univariate Cox proportional hazards regression model.
Multivariate Cox proportional hazards regression
analysis was performed to evaluate the independent
impact of PNI in predicting each time-to-event
outcome with the adjustment of other signiﬁcant
risk factors. Forward approach was adopted and
univariate hazard ratios of all potential risk factors
were calculated. Those with signiﬁcant inﬂuence
(i.e. P < 0.05) were included in ﬁnal multivariate Cox
proportional hazards regression model. All statistical analyses were performed using SPSS statistical
software (IBM SPSS Statistics for Windows, Version
24.0. Armonk, NY: IBM Corp.). All analyses were
two-tailed and P values of <0.05 were considered
statistically signiﬁcant.

Results
Study participants and patient characteristics
During the study period, 270 CLTI patients treated
with endovascular revascularization therapy (ERT)
were enrolled. Baseline demographics of the
enrolled patients were summarized in Table 1.
Among the entire study population, 53.0% (143/270)
of CLTI patients were male. The mean age of the
study group was 73.7 ± 11.9 years. Within the group,
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Table 1. Patient characteristics.

Male
Age (SD)
#Age >80
Rutherford classiﬁcation
N4
N5
N6
BMI25kg/m2
Current & Ex-smokers
Hypertension
Hyperlipidemia
Stroke/TIA
Heart failure
Coronary artery disease
DM
GFR (ml/min/1.73m2)
ESRF (on dialysis/GFR <15 ml/min/1.73m2)
Lesion location
FP & BTK
FP
BTK
Non-ambulatory status
PCI
CABG
Previous amputation
Previous limb revascularization
Insulin treatment

Overall
(N ¼ 270)

Group 1
Upper tertile
(PNI >45.5)
(n ¼ 91)

Group 2
Middle tertile
(PNI 37.6e45.5)
(n ¼ 89)

Group 3
Low tertile
(PNI 37.5)
(n ¼ 90)

P value

143 (53.0%)
73.7 (11.9)
92 (34.1%)

49 (53.8%)
73.8 (12.5)
31 (34.1%)

45 (50.6%)
76.1 (10.4)
33 (37.1%)

49 (54.4%)
71.1 (12.3)
28 (31.1%)

0.855
*0.022
0.701
*<0.001

51 (18.9%)
196 (72.6%)
23 (8.5%)
56 (25.9%)
128 (48.9%)
228 (84.4%)
107 (39.6%)
63 (23.3%)
55 (20.4%)
79 (29.3%)
179 (66.3%)
52.3 (33.6)
57 (21.1%)

24 (26.4%)
67 (73.6%)
0 (0.0%)
16 (21.1%)
47 (52.8%)
72 (79.1%)
29 (31.9%)
17 (18.7%)
11 (12.1%)
20 (22.0%)
53 (58.2%)
66.3 (27.6)
5 (5.5%)

21 (23.6%)
64 (71.9%)
4 (4.5%)
19 (28.8%)
40 (47.1%)
79 (88.8%)
38 (42.7%)
24 (27.0%)
18 (20.2%)
28 (31.5%)
59 (66.3%)
50.9 (29.4)
14 (15.7%)

6 (6.7%)
65 (72.2%)
19 (21.1%)
21 (28.4%)
41 (46.6%)
77 (85.6%)
40 (44.4%)
22 (24.4%)
26 (28.9%)
31 (34.4%)
67 (74.4%)
42.1 (38.5)
38 (42.2%)

108 (40.0%)
95 (35.2%)
67 (24.8%)
33 (12.2%)
25 (9.3%)
20 (7.4%)
54 (20.0%)
32 (11.9%)
79 (29.3%)

32 (35.2%)
33 (36.3%)
26 (28.6%)
8 (8.8%)
7 (7.7%)
6 (6.6%)
13 (14.3%)
12 (13.2%)
17 (18.7%)

35 (39.3%)
32 (36.0%)
22 (24.7%)
9 (10.1%)
9 (10.1%)
8 (9.0%)
16 (18.0%)
11 (12.4%)
31 (34.8%)

41 (45.6%)
30 (33.3%)
19 (21.1%)
16 (17.8%)
9 (10.0%)
6 (6.7%)
25 (27.8%)
9 (10.0%)
31 (34.4%)

0.484
0.655
0.191
0.173
0.403
*0.019
0.157
0.070
*<0.001
*<0.001
0.665

0.138
0.818
0.785
0.064
0.790
*0.024

PNI ¼ Prognostic Nutritional Index; BMI ¼ Body mass index; TIA ¼ Transient ischemic attack; DM ¼ Diabetes mellitus; ESRF ¼ End
stage renal failure; GFR ¼ Glomerular ﬁltration rate; FP ¼ Femoropopliteal; BTK ¼ Below the Knee; PCI¼ Percutaneous coronary
intervention; CABG ¼ Coronary artery bypass surgery; SD ¼ standard deviation.

18.9% (51/270) of CLTI patients presented with
Rutherford classiﬁcation stage 4, 72.6% (196/270) of
CLTI patients presented with Rutherford classiﬁcation stage 5, while only 8.5% (23/270) of CLTI patients presented with Rutherford classiﬁcation stage
6.25.9% (56/270) of CLTI patients had Body Mass
Index (BMI) equal to or more than 25 before endovascular intervention. 84.4% (228/270) of the study
population had hypertension while 66.3% (179/270)
of the study population had Diabetes mellitus (DM).
Hypertension and DM were the two most prevalent
co-morbidities among the enrolled patients, yet only
29.3% (79/270) of CLTI patients were on insulin
treatment in the entire cohort. In addition, the
prevalence of other chronic diseases such as heart
failure was 20.4% (55/270). 29.3% (79/270) of CLTI
patients had history of coronary artery disease
(CAD). The prevalence of end stage renal failure
(ESRF) in the study population was 21.1% (57/270).
Previous amputation rate of the enrolled patients
was 20.0% (54/270), while 11.9% (32/270) of the CLTI
patients had previously received lower limb revascularization. Only 12.2% (33/270) of the study

populations were non-ambulatory upon endovascular intervention.
The entire prospective CLTI cohort was stratiﬁed
in tertile manner based on the subjects’ PNI values.
Group 1 represented patients in the highest PNI
tertile (n ¼ 91) with the mean and the lower
boundary of PNI being 50.4 and 46.0 (>45.5)
respectively. Group 2 represented patients in middle PNI tertile (n ¼ 89) with the mean of PNI being
42.2 and range of PNI being 37.6e45.5 respectively.
Group 3 represented patients in the lowest PNI
tertile (n ¼ 90) with the mean and the upper
boundary of PNI being 32.8 and 37.5 (37.5). Group
PNI difference was tested with statistical signiﬁcance (p < 0.001) and indicated that the validity of
this grouping.
In general, different co-morbidities distribution
was observed among different groups. Patients in
the lowest PNI tertile (Group 3) had higher portions
of ESRF, heart failure and higher disease stage in
Rutherford classiﬁcation (all P < 0.05). In the lowest
PNI tertile (Group 3), 42.2% (38/90) of patients had
history of ESRF and 28.9% (26/90) of patients had

PNI ¼ Prognostic Nutritional Index; HR ¼ Hazard ratio; CI ¼ Conﬁdence Interval; AFS ¼ Amputation-free survival; Ref ¼ reference; LS ¼ limb salvage.

>45.5
3 (3.3%)
11.6 (11.2e12.0) 0.16 (0.05e0.56) 0.004 7 (7.7%)
11.4 (11.0e11.9) 0.12 (0.06e0.28) <0.001 9 (9.9%)
11.2 (10.6e11.7) 0.14 (0.07e0.29) <0.001
37.6e45.5 8 (9.0%)
11.2 (10.6e11.8) 0.47 (0.20e1.11) 0.084 20 (22.5%) 10.3 (9.6e11.0) 0.39 (0.23e0.67) 0.001
24 (27.0%) 9.8 (9.0e10.6)
0.42 (0.26e0.68) 0.001
37.5
15 (16.7%) 10.1 (9.2e11.0) Ref
e
43 (47.8%) 8.3 (7.3e9.2)
Ref
e
47 (52.2%) 7.3 (6.3e8.4)
Ref
e
1
2
3

HR (95% CI)
No. of
Mean AFS
Cases (%) time (95% CI)
No. of
Mean survival
Cases (%) time (95% CI)
P
HR (95% CI)
Mean LS time
(95% CI)
No. of
cases (%)
Group PNI

Table 2. Clinical outcomes after endovascular revascularization therapy (ERT).

As shown in Table 2, Patients in the highest PNI
tertile (Group 1) were associated with lowest incidence rate of composite endpoint of amputation and
all-cause mortality (9.9%) in the 12-month study
period. The all-cause mortality and amputation
were 7.7% and 3.3% respectively. For patients in the
middle PNI tertile (Group 2), the composite
endpoint of amputation and all-cause mortality was
27.0%, while all-cause mortality and amputation
were 22.5% and 9.0% respectively in the 12-month
study period. For patients in the lowest PNI tertile
(Group 3), the prognosis was the worst with the
composite endpoint of amputation and all-cause
mortality being 52.2%. All-cause mortality and
amputation were 47.8% and 16.7% respectively in
the 12-month study period. The signiﬁcance of
the difference among 3 PNI tertile groups was
conﬁrmed with univariate Cox regression hazards
models in composite outcomes and all-cause mortality (All P < 0.05). On the other hand, for amputation, only the comparison between the highest and
lowest PNI tertile could reach statistical signiﬁcance
(P < 0.05).
Moreover, patients in the lowest PNI tertile
(Group 3) were found to have the shortest mean
limb salvage (LS) time of 10.1 months, the shortest
mean survival time of 8.3 months and the shortest
amputation-free survival (AFS) time of 7.3 months.
Kaplan-Meier curves (Figures 1e3) demonstrated
that AFS, survival rates and LS rates were

All-cause Mortality (Survival)

Clinical outcomes after endovascular
revascularization therapy (ERT)

HR (95% CI)

P

Composite endpoint: Amputation and All-cause
Mortality (Amputation-free survival, AFS)

history of heart failure. 21.2% (19/90) of patients in
the lowest PNI tertile (Group 3) presented with
Rutherford classiﬁcation stage 6 compared to none
of patients in highest PNI tertile (Group 1). In
addition, renal function (GFR) decreased across the
groups with decreasing PNI, from 66.3 ml/min/
1.73m2 in Group 1 to 42.1 ml/min/1.73m2 in Group 3
(P < 0.001). The prevalence of insulin treatment was
higher in the lowest PNI tertile (Group 3) with statistical signiﬁcance (P < 0.05), which could be partly
attributed to poorer renal function and higher
prevalence of dialysis. Moreover, non-ambulatory
status (17.8%, 16/90) and history of previous amputation (27.8%, 25/90) appeared to be more prevalent
in the lowest PNI tertile (Group 3) yet with between
group comparisons they failed to reach statistical
signiﬁcance (P]NS). However, the distribution of
other co-morbidities such as smoking history, hypertension, diabetes mellitus, stroke and coronary
artery disease were not statistically signiﬁcant
among three tertile groups (P]NS).

P
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Amputation (Limb salvage)
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Figure 1. Amputation free survival (AFS) rate after endovascular revascularization therapy (ERT) for 270 Chronic limb-threatening ischemia (CLTI)
patients. Kaplan-Meier curves demonstrated that AFS was signiﬁcantly better among patients in the highest PNI tertile (P < 0.001).PNI ¼ Prognostic
nutritional index.

signiﬁcantly better among patient in the highest PNI
tertile (all P < 0.05).
Predictors of clinical outcome after endovascular
revascularization therapy (ERT)
For analysis of predictor of all-cause mortality after
ERT as shown in Table 3, after univariate and multivariate Cox regression hazards model, patients in the
highest PNI tertile (Group 1), ESRF, together with age
>80 remained statistically signiﬁcant predictor of allcause mortality. The adjusted hazard ratio of the
highest PNI tertile (Group 1) was 0.20 (95% CI:
0.09e0.49). The adjusted hazard ratio of ESRF was
2.19 (95% CI: 1.09e4.40). For the factor of age >80, the
adjusted hazard ratio was 2.48 (95% CI: 1.41e4.35).
For analysis of predictor of amputation after ERT
as shown in Table 4, after univariate and multivariate Cox regression hazards model, only ESRF and
non-ambulatory status remained statistically signiﬁcant predictor of amputation. The adjusted hazard ratio of ESRF was 5.12 (95% CI: 1.74e15.06)
while the adjusted hazard ratio of non-ambulatory

status was 3.90 (95% CI: 1.58e9.62) respectively.
After univariate and multivariate Cox regression
hazards model, PNI became statistically insigniﬁcant (P]NS). The reason behind could be due to the
incorporation of ESRF and non-ambulatory status
into analysis attenuating the association between
PNI and the outcomes of limb amputation.
PNI is an independent predictor of composite
endpoint including amputation and all-cause mortality after ERT. As shown in Table 5, univariate
analysis revealed several signiﬁcant risk factors
inﬂuencing composite endpoint during 12-month
follow-up, including PNI, age >80, higher Rutherford classiﬁcation (N5 & N6), non-ambulatory
status, ESRF, history of heart failure, coronary artery
disease and on insulin treatment. After the multivariate Cox regression hazards model, only PNI,
ESRF, non-ambulatory status, together with age >80
remained statistically signiﬁcant. The adjusted hazard ratio of ESRF was 3.14 (95% CI: 1.63e6.03). The
adjusted hazard ratio of non-ambulatory status was
2.42 (95% CI: 1.37e4.29). The adjusted hazard ratio
of age >80 was 1.82 (95% CI: 1.07e3.11). Patients in
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Figure 2. Survival rate after endovascular revascularization therapy (ERT) for 270 Chronic limb-threatening ischemia (CLTI) patients. Kaplan-Meier
curves demonstrated that survival rate was signiﬁcantly better among patients in the highest PNI tertile (P < 0.001). PNI ¼ Prognostic nutritional
index.

the highest PNI tertile (Group 1) was a strong independent predictor of the composite endpoint (HR
0.26, 95% CI: 0.12e0.57).
Subgroup analysis
In order to evaluate the interaction effect between
PNI and other risk factors of composite endpoint
(age>80; ESRF and non-ambulatory status), subgroup analyses were performed. As shown in
Figure 4, it illustrated the hazard ratio and 95% CI
per 1-standard deviation increase of PNI in different
subgroups. All HRs were shown to be less than 1
and this suggested that the protective function of
higher PNI on composite endpoint (amputation and
all-cause mortality) was valid in various subgroups
(age>80 or <80 years, End stage renal failure (ESRF)
or without ESRF, patients at non-ambulatory status
or ambulatory status). In addition, P values of the
interaction terms were all insigniﬁcant and this
showed that there were no signiﬁcant interaction
effects between PNI and other risk factors. Higher

PNI was consistently associated with the lowest
incidence of composite endpoint in the following
subgroup populations: age>80 or <80 years, ESRF or
without ESRF, CLTI patients at non-ambulatory
status or ambulatory status.
Use of Receiver Operating Characteristic (ROC)
curve
ROC curve was performed to determine potential
cut-off PNI level for predicting the incidence of
negative outcomes after ERT. All 3 ROC curves
demonstrated that PNI value of 41.75 was the
optimal cut-off values with statistical signiﬁcance
(All P < 0.05). The Area under the Curve (AUC) for
composite endpoint (amputation and all-cause
mortality) was 0.767 with sensitivity and speciﬁcity
being 0.825 and 0.647 (Figure 5). AUC for all-cause
mortality was 0.773 with sensitivity and speciﬁcity
being 0.829 and 0.625 (Figure 6). For amputation,
AUC was 0.714 with the sensitivity and speciﬁcity
being 0.808 and 0.541 respectively (Figure 7).
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Figure 3. Limb salvage rate after endovascular revascularization therapy (ERT) for 270 Chronic limb-threatening ischemia (CLTI) patients. KaplanMeier curves demonstrated that limb salvage was signiﬁcantly better among patients in the highest PNI tertile (P < 0.004).PNI ¼ Prognostic nutritional
index.

Discussion
Predictors of clinical outcome after
endovascular revascularization therapy (ERT)
Prior studies have identiﬁed that various factors
were associated with poor prognosis of patients with
CLTI as shown in Bypass versus angioplasty in severe ischemia of the leg (BASIL), Finland National
Vascular (FINNVASC) and 2-year life expectancy
(2YLE) studies [7e9]. Factors that were commonly
associated with amputation, mortality and amputation-free survival (AFS) included non-ambulatory
status, dialysis dependence, heart failure history
and Rutherford classiﬁcation. The results of this
study were generally in agreement with the above
studies. It is shown that the presence of heart failure
negatively impacts patient prognosis without
exception, including CLTI patients. Furthermore, as
chronic kidney disease progresses, the results also
worsen and patients on dialysis have very poor
outcomes. Dialysis dependence was also one of the
most important risk factors in our study population.
Diabetes is one of the major risk factors for lower
limb amputation in patients with CLTI [8]. A high
incidence of infrapopliteal lesions, neurological

disorders, increased susceptibility to infection, lower
limb deformity, and renal impairment were considered as contributing factors in patients with diabetes
[14e16]. However, diabetes was not an independent
factor associated with amputation and mortality in
the present analysis, of which 66.3% patients had
diabetes. It may be explained that the incorporation
of end stage renal failure or dialysis dependence into
analysis attenuated the association between diabetes
and mortality and the outcomes of limb amputation.
Other than the above risk factors, nutritional
dysfunction was commonly neglected in patients with
CLTI. Patients with CLTI could be complicated with
wound infection or even active sepsis, and these would
lead to chronic inﬂammation. Albumin was also
shown to be a predictor of poor outcome in patients
with CLTI. Previous literature suggested poor preoperative hypoalbuminemia is associated with
morbidity and mortality after infrainguinal lower extremity bypass for CLTI [17]. Evaluation and optimization of nutritional status should be performed
preoperatively in this high-risk population. Yet, the
signiﬁcance of albumin was not consistent in all registries [5e7]. Albumin could partly reﬂect patient's
nutrition status; nonetheless, due to the character of
acute-phase proteins, variations during acute
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Table 3. Predictors of all-cause mortality after endovascular revascularization therapy (ERT).
Univariate Analysis

PNI
37.5 [group 3]
37.6e45.5 [group 2]
>45.5 [group 1]
Male
Age >80
Rutherford classiﬁcation
N6
N5
N4
BMI25kg/m2
Current & Ex-smokers
Hypertension
Hyperlipidemia
Stroke/TIA
Heart failure
Coronary artery disease
DM
ESRF (on dialysis/GFR <15 ml/min/1.73m2)
Non-ambulatory
PCI
CABG
Previous amputation
Previous lower limb revascularization
Insulin treatment

Multivariate Analysis

HR

95% CI

P value

HR

95% CI

P value

Ref
0.39
0.12
0.77
1.86

e
0.23e0.67
0.06e0.28
0.48e1.23
1.16e2.97

e
*0.001
*<0.001
0.282
*0.010

Ref
0.54
0.20
e
2.48

e
0.30e0.99
0.09e0.49
e
1.41e4.35

e
*0.048
*<0.001
e
*0.002

4.62
2.19
Ref
1.12
0.67
0.71
1.11
1.18
2.71
2.14
1.45
3.52
3.01
1.39
0.95
0.81
1.11
1.87

1.79e11.91
1.00e4.82
e
0.59e2.12
0.41e1.09
0.39e1.27
0.69e1.79
0.69e2.01
1.67e4.40
1.33e3.44
0.85e2.45
2.19e5.66
1.76e5.16
0.67e2.91
0.38e2.37
0.44e1.51
0.55e2.24
1.16e3.01

*0.002
0.052
e
0.727
0.107
0.243
0.657
0.556
*<0.001
*0.002
0.171
*<0.001
*<0.001
0.377
0.919
0.513
0.766
*0.010

1.67
1.24
Ref
e
e
e
e
e
1.39
1.48
e
2.19
1.52
e
e
e
e
1.14

0.61e4.58
0.55e2.81
e
e
e
e
e
e
0.80e2.41
0.86e2.54
e
1.09e4.40
0.82e2.79
e
e
e
e
0.61e2.16

0.318
0.607
e
e
e
e
e
e
0.243
0.160
e
*0.027
0.181
e
e
e
e
0.680

PNI ¼ Prognostic Nutritional Index; HR ¼ Hazard ratio; CI ¼ Conﬁdence Interval; BMI ¼ Body mass index; TIA ¼ Transient ischemic
attack; DM ¼ Diabetes mellitus ESRF ¼ End stage renal failure; GFR ¼ Glomerular ﬁltration rate; PCI ¼ Percutaneous coronary
intervention; CABG ¼ Coronary artery bypass surgery.
Table 4. Predictors of amputation after endovascular revascularization therapy (ERT).
Univariate Analysis

PNI
37.5 [group 3]
37.6e45.5 [group 2]
>45.5 [group 1]
Male
Age >80
Rutherford classiﬁcation
N6
N5
N4
BMI25kg/m2
Current & Ex-smokers
Hypertension
Hyperlipidemia
Stroke/TIA
Heart failure
Coronary artery disease
DM
ESRF (on dialysis/GFR <15 ml/min/1.73m2)
Non-ambulatory
PCI
CABG
Previous amputation
Previous lower limb revascularization
Insulin treatment

Multivariate Analysis

HR

95% CI

P value

HR

95% CI

P value

Ref
0.47
0.16
0.45
0.72

e
0.20e1.11
0.05e0.56
0.20e1.01
0.30e1.72

e
0.084
*0.004
0.054
0.461

Ref
0.89
0.38
e
e

e
0.34e2.31
0.10e1.47
e
e

e
0.809
0.162
e
e

3.77
1.80
Ref
1.97
0.42
1.00
1.16
0.42
0.76
2.28
2.25
6.23
4.17
0.40
2.36
1.54
0.95
2.61

0.84e16.88
0.53e6.09
e
0.70e5.54
0.17e1.01
0.35e2.91
0.53e2.52
0.13e1.41
0.26e2.19
1.06e4.94
0.85e5.96
2.86e13.68
1.81e9.63
0.05e2.94
0.81e6.86
0.65e3.66
0.29e3.17
1.21e5.63

0.083
0.344
e
0.198
0.052
0.997
0.713
0.162
0.606
*0.036
0.104
*<0.001
*<0.001
0.367
0.114
0.331
0.936
*0.015

e
e
e
e
e
e
e
e
e
1.31
e
5.12
3.90
e
e
e
e
0.79

e
e
e
e
e
e
e
e
e
0.58e2.96
e
1.74e15.06
1.58e9.62
e
e
e
e
0.29e2.13

e
e
e
e
e
e
e
e
e
0.523
e
*0.003
*0.003
e
e
e
e
0.639

PNI ¼ Prognostic Nutritional Index; HR ¼ Hazard ratio; CI ¼ Conﬁdence Interval; BMI ¼ Body mass index; TIA ¼ Transient ischemic
attack; DM ¼ Diabetes mellitus ESRF ¼ End stage renal failure; GFR ¼ Glomerular ﬁltration rate; PCI ¼ Percutaneous coronary
intervention; CABG ¼ Coronary artery bypass surgery.
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Table 5. Predictors of composite endpoint of amputation and all-cause mortality after endovascular revascularization therapy (ERT).
Univariate Analysis

PNI
37.5 [group 3]
37.6e45.5 [group 2]
>45.5 [group 1]
Male
Age >80
Rutherford classiﬁcation
N6
N5
N4
BMI25kg/m2
Current & Ex-smokers
Hypertension
Hyperlipidemia
Stroke/TIA
Heart failure
Coronary artery disease
DM
ESRF (on dialysis/GFR <15 ml/min/1.73m2)
Non-ambulatory
PCI
CABG
Previous amputation
Previous lower limb revascularization
Insulin treatment

Multivariate Analysis

HR

95% CI

P value

HR

95% CI

P value

Ref
0.42
0.14
0.72
1.56

e
0.26e0.68
0.07e0.29
0.46e1.12
1.00e2.43

e
*0.001
*<0.001
0.143
*0.049

Ref
0.67
0.26
e
1.82

e
0.38e1.16
0.12e0.57
e
1.07e3.11

e
0.149
*0.001
e
*0.027

5.94
2.58
Ref
1.34
0.72
0.87
1.19
1.03
2.22
2.23
1.56
4.07
3.98
1.15
1.29
1.04
0.92
1.94

2.37e14.90
1.18e5.64
e
0.75e2.42
0.46e1.13
0.49e1.54
0.76e1.85
0.61e1.72
1.40e3.54
1.43e3.47
0.95e2.57
2.61e6.34
2.43e6.52
0.55e2.38
0.59e2.80
0.60e1.79
0.46e1.85
1.24e3.03

*<0.001
*0.018
e
0.326
0.152
0.622
0.442
0.925
*0.001
*<0.001
0.080
*<0.001
*<0.001
0.776
0.519
0.896
0.818
*0.003

2.09
1.39
Ref
e
e
e
e
e
1.02
1.55
e
3.14
2.42
e
e
e
e
0.89

0.78e5.62
0.62e3.14
e
e
e
e
e
e
0.60e1.75
0.94e2.56
e
1.63e6.03
1.37e4.29
e
e
e
e
0.49e1.60

0.143
0.425
e
e
e
e
e
e
0.931
0.087
e
*0.001
*0.002
e
e
e
e
0.690

PNI ¼ Prognostic Nutritional Index; HR ¼ Hazard ratio; CI ¼ Conﬁdence Interval; BMI ¼ Body mass index; TIA ¼ Transient ischemic
attack; DM ¼ Diabetes mellitus ESRF ¼ End stage renal failure; GFR ¼ Glomerular ﬁltration rate; PCI ¼ Percutaneous coronary
intervention; CABG ¼ Coronary artery bypass surgery.

Figure 4. Subgroup analyses of interaction effect between Prognostic nutritional Index (PNI) and other risk factors. It illustrated the hazard ratio (HR)
and 95% conﬁdence interval (CI) per 1-standard deviation increase of prognostic nutritional index (PNI) in different subgroups. All HRs were shown
to be less than 1 and this suggested that the protective function of higher PNI on composite endpoint (amputation and all-cause mortality) was valid in
various subgroups (age>80 or <80 years, End stage renal failure (ESRF) or without ESRF, patients at non-ambulatory status or ambulatory status).

inﬂammation might occur. Combined with lymphocyte counts, Prognostic nutritional factor (PNI) could
be more representative to predict clinical outcomes in
patient with CLTI.

Nutritional status and the prognosis of CLTI
The present study demonstrated that nutrition
status, in patients with CLTI undergoing ERT, was

independently associated with all-cause mortality
and amputation. PNI, which was derived from
serum albumin and total lymphocyte count,
revealed more prognostic predictive power than its
components alone. The overall clinical outcome was
comparable to previous OLIVE registry and BASIL
trial [6,7]. Along with advanced age (age >80), nonambulatory status and ESRF, PNI is an independent
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Figure 5. Receiver Operating Characteristic (ROC) curve for composite
endpoint (amputation and all-cause mortality). AUC = Area under curve.

Figure 7. Receiver Operating Characteristic (ROC) curve for amputation.
AUC = Area under curve

predictor of amputation free survival in the multivariate model. In addition, as shown in subgroup
analysis, protective function of higher PNI on composite endpoint (amputation and all-cause mortality) was valid in various subgroups (age>80 or <80
years, End stage renal failure (ESRF) or without
ESRF, patients at non-ambulatory status or ambulatory status).

As a result, poor nutritional status correlates with
increasing risks of postoperative morbidity and mortality, prolonged hospital stays, as well as poor quality
of life [22,23]. Thus, in patients with CLTI and
malnutrition, delayed wound healing and wound
infection often lead to amputation eventually. There
were several hypotheses that could account for low
PNI in patients with CLTI. Firstly, many patients with
low PNI also suffered from chronic kidney disease or
even end stage renal failure (ESRF). A number of
conditions often related to ESRF, such as malnutrition
or even cachexia, hypoalbuminemia, depressed immunity, and insufﬁcient collagen in granulation tissue
could also lead to amputation and mortality in the
present study. Secondly, chronic inﬂammation could
lead to change of albumin level, due to its nature of
“Negative” acute-phase proteins. Thirdly, it is was not
uncommon that CLTI patients suffer from wound
healing problems or even active infections, which can
lead to lymphocytopenia and low PNI. And the presence of wound infection in the lower limb is a widely
accepted factor increasing the demand for blood ﬂow
to the microvascular bed and consequently resulted in
a poorer prognosis in our patients.

Determinants of nutritional status in CLTI
Nutritional dysfunction was not uncommon in patients with CLTI and it could account for the poor
outcomes [18]. Malnutrition is associated with
decreased immune system function, impaired respiratory function and poor wound healing [19e21].

Role of prognostic nutritional index (PNI) in
CLTI

Figure 6. Receiver Operating Characteristic (ROC) curve for all-cause
mortality. AUC = Area under curve.

Prognostic nutritional index (PNI) is a simple
nutritional assessment calculated from routine
biochemistry and haemogram. It combines malnutrition and inﬂammation factors to predict outcomes
after cancer surgery and heart failure [10,11].
Nutritional intervention may even improve clinical
outcomes with less hospitalization and medical cost,
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especially in older patients with heart failure [24]. In
patients with CLTI who undergo ERT, pre-operative
PNI could serve a role to predict the outcomes after
the procedures. By this simple nutritional assessment, PNI could help guide clinical practice by
better risk stratiﬁcation of patients with CLTI who
undergo ERT, and initiating early nutritional support and intervention, which may improve clinical
outcomes. Previous literature suggested that multidisciplinary care, including resistance training and
nutritional therapy, could improve sarcopenia and
prognosis of CLTI patients [25,26]. Consequently, a
clinically signiﬁcant nutritional index is indicated
for risk stratiﬁcation and clinical management of
CLTI.

Conclusion

Strength of the study

The study protocol was approved by the ethics
committee of New Territories East Cluster of Hospital Authority in Hong Kong.

This study is a real world prospective clinical
registry from a single tertiary referral center. The
sample size was not small. The overall clinical
outcome was comparable to previous OLIVE registry and BASIL trial [6,7]. Patients’ outcome was
closely reviewed during follow-up and through
clinical management system of Hospital Authority,
the Hong Kong Special Administrative Region.
Compared with previous BASIL trial, our current
study only enrolled patients with chronic limbthreatening ischemia. This study also enrolled patients with ESRF or dialysis dependence. A high
primary procedural success rate was achieved in our
cohort of patients.

Study limitations
Limitations of this study include its registry nature
and the potential for referral/selection bias in a
single center. The study population included Chinese mainly, and thus the results may not necessarily be extrapolated to other populations.
Concerning on the treatment strategy, the results of
endovascular treatment were not evaluated at a
central laboratory. Similarly, clinical assessment for
the patients’ outcomes or events were also not
evaluated by a central laboratory . Some other factors such as C-reactive protein level, neutropril-tolymphocyte ratio, post-ERT numbers of foot vessels
and WIfI wound status are potentially good predictors for limb salvage yet they were not included
in this cohort. The PNI data was collected only on
admission for ERT, but not at discharge or during
follow-up. Whether PNI could be modiﬁed after
ERT remained unknown. More studies are warranted to investigate whether PNI would be
changed after ERT or nutritional intervention.

Nutritional status is an important but often neglected prognostic factor in patients with severe peripheral
arterial disease presenting with chronic limb-threatening ischemia. In this study, we demonstrated that
PNI is a simple risk score which can be used to risk
stratify and predict prognosis in patients with chronic
limb-threatening ischemia who underwent endovascular revascularization therapy. Further studies are
warranted to investigate whether PNI could be used as
a tool to guide therapy and follow-up after endovascular revascularization therapy or nutritional
intervention.
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